LRCX
46
-2
RIG
44
-2
LOW
58
2
NI
73
3
RSG
77
4
RRC
60
-3
HPE
70
2
PCG
99
2
LNC
45
-4
GIS
29
3
CTSH
65
-3
BA
45
-3
MA
67
-5
MMM
42
5
NSC
64
2
LB
63
-4
LEN
52
2
TEL
74
3
NTAP
61
-3
AVY
53
2
LRCX
46
-2
RIG
44
-2
LOW
58
2
NI
73
3
RSG
77
4
RRC
60
-3
HPE
70
2
PCG
99
2
LNC
45
-4
GIS
29
3
CTSH
65
-3
BA
45
-3
MA
67
-5
MMM
42
5
NSC
64
2
LB
63
-4
LEN
52
2
TEL
74
3
NTAP
61
-3
AVY
53
2
Financhill
Back

Protalix BioTherapeutics Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
64

PLX
Protalix BioTherapeutics

Last Price:
1.41
Seasonality Move:
72.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Protalix BioTherapeutics Price Quote

$1.41
+0.17 (+13.71%)
(Updated: November 14, 2024 at 5:55 PM ET)

Protalix BioTherapeutics Key Stats

Buy
64
Protalix BioTherapeutics (PLX) is a Buy
Day range:
$1.23 - $1.31
52-week range:
$0.82 - $1.90
Dividend yield:
0%
P/E ratio:
14.67
P/S ratio:
2.75
P/B ratio:
3.4%
Volume:
304.6K
Avg. volume:
198.9K
1-year change:
-8.15%
Market cap:
$97.1M
Revenue:
$65.5M
EPS:
$-0.23

How Much Does Protalix BioTherapeutics Make?

Is Protalix BioTherapeutics Growing As A Company?

Protalix BioTherapeutics Stock Price Performance

What Is Protalix BioTherapeutics 52-Week High & Low?

Protalix BioTherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Protalix BioTherapeutics?

Is Protalix BioTherapeutics Cash Flow Positive?

  • What Is PLX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$2.7M
  • What Is Protalix BioTherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Protalix BioTherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$22M

Protalix BioTherapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PLX return on invested capital is -27.15%
  • What Is Protalix BioTherapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -16.63%
  • What Is PLX Return On Equity?
    ROE is a measure of profitability and is -43.43%

Protalix BioTherapeutics Earnings Date & Stock Price

Protalix BioTherapeutics Competitors

Protalix BioTherapeutics Dividend Yield

Protalix BioTherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -61.59% -60.03%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.00
Upside from Last Price: 1029.03%

Major Shareholders

  • How many PLX shares are owned by institutional investors?
    6.9M PLX shares are owned by institutional investors
  • How many PLX shares are owned by insiders?
    4.7M PLX shares are owned by insiders